- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 29.07. | Genetic Analysis AS and Pangea Laboratory LLC announces the launch of GA-map MHI GutHealth in the USA | 2 | Cision News | ||
| 27.06. | GENETIC ANALYSIS AS: Genetic Analysis subsequent offering to existing shareholders has now been registered with the Norwegian Register of Business Enterprises | 1 | Cision News | ||
| GENETIC ANALYSIS Aktie jetzt für 0€ handeln | |||||
| 18.06. | GENETIC ANALYSIS AS: Genetic Analysis announces final outcome of the subsequent offering to existing shareholders | 1 | Cision News | ||
| 18.06. | GENETIC ANALYSIS AS: Genetic Analysis: Direct issue has now been registered with the Norwegian Register of Business Enterprises | 1 | Cision News | ||
| 16.06. | GENETIC ANALYSIS AS: Genetic Analysis announces preliminary outcome of the subsequent offering to existing shareholders | 1 | Cision News | ||
| 12.06. | Genetic Analysis AS: Mandatory notification of trade | 1 | Cision News | ||
| 12.06. | GENETIC ANALYSIS AS: Today is the last day for trading in the subscription rights for subscribing for shares in Genetic Analysis | 1 | Cision News | ||
| 05.06. | GENETIC ANALYSIS AS: Today the subscription period in Genetic Analysis subsequent offering begins | 1 | Cision News | ||
| 03.06. | GENETIC ANALYSIS AS: Genetic Analysis first day of trading excluding subscription rights | 2 | Cision News | ||
| 03.06. | XFRA CAPITAL ADJUSTMENT INFORMATION - 03.06.2025 | 467 | Xetra Newsboard | Das Instrument TGNA FR0005175080 TRANSGENE SA EO 0,50 EQUITY wird cum Kapitalmassnahme gehandelt am 03.06.2025 und ex Kapitalmassnahme am 04.06.2025 The instrument TGNA FR0005175080 TRANSGENE SA EO... ► Artikel lesen | |
| 02.06. | GENETIC ANALYSIS AS: Genetic Analysis publishes Simplified disclosure document relating to the previously announced subsequent offering | 4 | Cision News | ||
| 02.06. | Spotlight Stock Market: Market Notice 99/25 - Information regarding the rights issue from Genetic Analysis AS | 2 | Cision News | ||
| 02.06. | GENETIC ANALYSIS AS: Genetic Analysis Last day of trading including subscription rights | 2 | Cision News | ||
| 27.05. | GENETIC ANALYSIS AS: Correction: Publication of Q1 report January - March 2025 | 2 | Cision News | ||
| 27.05. | GENETIC ANALYSIS AS: Genetic Analysis announces details of Subsequent Offering following directed issue | 2 | Cision News | ||
| 27.05. | GENETIC ANALYSIS AS: Publication of Q1 report January - March 2025 | 2 | Cision News | ||
| 20.05. | Genetic Analysis AS: Mandatory notification of trade | 1 | Cision News | ||
| 20.05. | Minutes from the Annual General Meeting 2024 in Genetic Analysis AS | 3 | Cision News | ||
| 05.05. | GENETIC ANALYSIS AS: Correction: Genetic Analysis announces placement of a directed share issue of NOK 12.8 million | 1 | Cision News | ||
| 05.05. | GENETIC ANALYSIS AS: Genetic Analysis announces placement of a directed share issue of NOK 12.8 million | 1 | Cision News |
1 2 Weiter >>
24 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BAXTER | 20,560 | -0,96 % | Dividendenbekanntmachungen (29.08.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ACNB CORPORATION US0008681092 0,34 USD 0,2911 EUR ADVANCED DRAINAGE SYSTEMS INC US00790R1041 0,18 USD 0,1541 EUR AEBI SCHMIDT HOLDING... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 23,880 | 0,00 % | BrightSpring Health Services, Inc. Reports First Quarter 2025 Financial Results and Increases Full Year 2025 Guidance | LOUISVILLE, Ky., May 02, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| PROGYNY | 23,410 | 0,00 % | Progyny, Inc. Announces Second Quarter 2025 Results | Reports Record Revenue of $332.9 Million, Reflecting 9.5% GrowthGenerates $55.5 Million in Quarterly Operating Cash Flow and Record $105.3 Million over the First Half of 2025 Raises Full Year Guidance... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 46,800 | +1,17 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 42,070 | +0,89 % | UBS stuft FMC FRESENIUS MEDICAL CARE AG auf 'Sell' | ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat das Kursziel für die Aktien von FMC von 43,50 auf 38 Euro gesenkt und die Papiere von "Neutral" auf "Sell" abgestuft. Analyst Graham Doyle... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 39,560 | 0,00 % | Assessing PROCEPT BioRobotics: Insights From 4 Financial Analysts | ||
| LIFESTANCE HEALTH GROUP | 5,630 | 0,00 % | LifeStance Health Group, Inc.: LifeStance Reports Second Quarter 2025 Results | SCOTTSDALE, Ariz., Aug. 07, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| ATRICURE | 36,290 | 0,00 % | AtriCure, Inc. - S-8, Securities to be offered to employees in employee benefit plans | ||
| FRESENIUS | 46,670 | +0,37 % | UBS stuft Fresenius SE auf 'Buy' | ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat das Kursziel für Fresenius von 49 auf 57 Euro angehoben und die Einstufung auf "Buy" belassen. Die Phase steigender Markterwartungen sei bei... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 16,640 | 0,00 % | Analyst Favors Cigna, Alignment Healthcare, Cautious On Peers | ||
| AVEANNA HEALTHCARE | 8,240 | 0,00 % | Moody's stuft Rating für Aveanna Healthcare auf B3 hoch - Ausblick stabil | ||
| ADAPTHEALTH | 9,150 | 0,00 % | AdaptHealth Corp. - 10-Q, Quarterly Report | ||
| GENEDX | 128,18 | 0,00 % | Rackspace US, Inc.: Rackspace Technology und Sema4.ai stellen die erste skalierbare KI-Agent-Lösung für Unternehmen vor | Die unternehmensgerechte Lösung schließt die Lücke zwischen KI-Experimenten und umfassender TransformationSAN ANTONIO, June 18, 2025®) und die Anwendungsmanagement-Expertise von Rackspace mit der fortschrittlichen... ► Artikel lesen | |
| KESTRA MEDICAL TECHNOLOGIES | 16,120 | 0,00 % | Kestra Medical Technologies, Ltd.: Kestra Medical Technologies Reports Fourth Quarter and Fiscal Year 2025 Financial Results | KIRKLAND, Wash., July 15, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a wearable medical device and digital healthcare company, today reported financial results for... ► Artikel lesen | |
| HEARTFLOW | 31,160 | 0,00 % | Wall Street analysts initiate AI diagnostic co HeartFlow with bullish views |
Das Unternehmen GENETIC ANALYSIS AS kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 0,057 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu GENETIC ANALYSIS AS finden Sie auf Wallstreet Online.